Welcome to the ACT Member Network

Registration Open for ACT's Free Educational Webinar on December 19

Having trouble viewing this message? A version is available online.
Please forward this to others who you feel may be interested in this course.

You are Invited to Participate in a Free Educational Webinar

Safety Assessment of Monoclonal Antibodies for Immunosuppressants and Anti-Inflammatory Agents

Wednesday, December 19, 2018

Time: 11:00 AM ET

Hosted by the American College of Toxicology

In Collaboration with the British Toxicology Society and the Society of Toxicologic Pathology

Speakers:

Simone Nicholson, PhD, DABT
Senior Toxicologist, Biologics Safety Assessment, MedImmune LLC

Talk 1: Introduction: Biologics for the Treatment of Immune-Mediated Inflammatory Disease

Hervé Lebrec, PharmD, PhD, DABT
Scientific Director, Nonclinical Safety Sciences, Amgen Inc.

Talk 2: Immune Safety Assessments for Immunosuppressive Agents: Tools and Applications

Shawn Heidel, DVM, PhD
Vice President and Head, Global Safety Assessment, Covance Laboratories, Inc.

Talk 3: Carcinogenicity Assessment of Biologics

Ken Hastings, DrPH, DABT, ATS
Hastings Toxicology Consulting, LLC

Talk 4: Regulatory Aspects and Interpretation of Immunosuppression AE in Nonclinical Studies

There is no fee but advance registration is required.

View Abstract

ACT Educational Webinar

Please forward this invitation to others you feel might be interested in this webinar.


You may view the ACT Privacy Policy, provide consent to ACT to email you communications, or unsubscribe to stop receiving further ACT communication.
Privacy Policy   |   Provide Consent   |   Unsubscribe

Recent Stories
Last Call: ACT's 2019 Annual Meeting Session Proposals

Last Call: ACT’s Free Educational Webinar on December 19

Registration Open for ACT's Free Educational Webinar on December 19